Re: non-psychotropic marijuana like molecule may be effective against her2+ breast ca
While this abstract gives hope in one way, it dashes it in another (quote):
"BACKGROUND: ErbB2-positive breast cancer is characterized by highly aggressive phenotypes and reduced responsiveness to standard therapies. Although specific ErbB2-targeted therapies have been designed, only a small percentage of patients respond to these treatments and most of them eventually relapse...."
I keep reading this kind of statement in papers published about Her2 breast cancer. Each time I get depressed with the implied futility of everything we do fighting this disease. I hope this kind of statement is more hyperbole than fact.
bird
__________________
Male Breast Cancer, DX 5/15/09, IDC, STAGE 1, 1.7 cm, HER2+++, ER+(95%)/PR+(75%), Ki67 40%, grade 3, 0/5 nodes, TX: mastectomy, TCH finished 7/19/10, radiation 6 wks., Tamoxifen on going, bisphosphonate 24 mos.
|